Reishi
Ganoderma lucidumStudies so far
- Lab dish8
- Animals1
- Early human trials
- Controlled trials1
- Approved use
Tested in controlled human trials
A sister species approved in China for chemo side effects
In 2010 China approved tablets made from Ganoderma sinense, a sister species of reishi, to treat low white blood cells and blood-forming damage from chemo or radiation. Both species are listed as lingzhi in the Chinese Pharmacopoeia.
Cochrane review of reishi in cancer patients
Five small trials found no support for reishi alone. Added to chemo or radiation, patients were more likely to respond and reported better quality of life, but the trials were low quality.
Hemlock reishi and colorectal tumors in mice
Hemlock reishi (Ganoderma tsugae), a close reishi relative, shrank colorectal tumors in mice with no detectable changes in the animals' health.
Ganoderic acid T and colon cancer spread
Ganoderic acid T, a reishi compound, made colon cancer cells stick together and move less, a sign of reduced invasion.
Ganoderic acid Me and colon cancer cells
Ganoderic acid Me killed colon cancer cells by damaging their mitochondria, the cell's power plants.
Reishi extract and stomach cancer cells
Reishi extract made stomach cancer cells self-destruct in dishes, triggering both of their built-in death pathways.
Ganoderic acids and cervical cancer cells
Two reishi ganoderic acids killed cervical cancer cells, and one spared normal cells better than the other.
Reishi and the HPV cancer protein
A reishi extract cut production of E6, the HPV 16 protein that drives cervical cancer, in cancer cells.
Reishi and DNA repair after radiation
Reishi polysaccharides helped human cells repair DNA damage caused by radiation.
Reishi glycopeptide and leukemia cells
A sulfated reishi glycopeptide slowed mouse leukemia cells in dishes.
Reishi and shaggy ink cap in prostate cancer cells
Reishi and shaggy ink cap extracts each blocked hormone-driven growth of prostate cancer cells, likely by interfering with the androgen receptor.